PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 28, 2026Cells2 citationsOpen Access

The Genotoxic Stress Sensor ZBP1 Drives Tau Pathology

View Full Paper
JTJessica M. ThanosOCOlivia C. CampbellNNNick R. Natale

Key Points

  • This work aims to explore the role of ZBP1 in tau pathology and its potential as a therapeutic target in neurodegenerative diseases.
  • Used the PS19 mouse model of tauopathy
  • Investigated effects of ZBP1 deletion on tau pathology
  • Assessed microglial and astrocytic activation levels
  • ZBP1 deletion reduced tau pathology and neuronal loss
  • Decreased activation of microglia and astrocytes was observed with ZBP1 ablation
  • Findings indicate ZBP1 as a central driver of neurodegeneration in tauopathies

Abstract

Genotoxic stress, which includes DNA damage and the mis-localization of DNA and RNA, is a defining feature of tauopathies, Alzheimer’s disease, and several other neurodegenerative disorders. Recent findings indicate that activation of the innate immune system in response to genotoxic stress can drive harmful neuroinflammation, compromise neuronal integrity, and promote neurodegeneration. Multiple innate immune sensors of genotoxic stress have recently been discovered, but the contributions of many of these emerging nucleic acid–sensing pathways in neurodegenerative disease pathogenesis remain largely unexplored. Z-DNA binding protein 1 (ZBP1) is one such recently discovered genotoxic stress sensor that has been shown to incite various forms of cell death as well as proinflammatory cytokine production in response to left-handed Z conformations of DNA (Z-DNA) and RNA (Z-RNA). Here, we show that ZBP1 deletion provides protection against tau pathology and neuronal loss in the PS19 mouse model of tauopathy. Moreover, we find that this rescue of tauopathy seen with ZBP1 ablation is associated with dampened activation of microglia and astrocytes. These findings identify ZBP1 as a pivotal genotoxic stress sensor that drives tau pathology, gliosis, and neuronal loss in tauopathy. This work further suggests that targeting ZBP1 may offer a therapeutic strategy to treat tau-mediated neurodegenerative disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Thanos et al. (2026) studied this question.

synapsesocial.com/papers/69c771688bbfbc51511e15f0https://doi.org/10.3390/cells15070591
Ask AI
Helpful
Bookmark
Share
View Full Paper